Houston Methodist Hospital System
Houston, Texas, 77030, United States
Location status: Recruiting
Location contact
Atiya Dhala, MD
PRINCIPAL_INVESTIGATOR
Darrel Cleere, BSN
CONTACT
Shondra Word
CONTACT
NCT Number: NCT06886256
This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.
Interested in participating?
Request Info55 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Location status: Recruiting
Atiya Dhala, MD
PRINCIPAL_INVESTIGATOR
Darrel Cleere, BSN
CONTACT
Shondra Word
CONTACT
This pilot study is a prospective, non-randomized, interventional trial of measures of prehabilitation in kidney transplant candidates who are frail. Kidney transplant candidates who meet criteria for the study will have wearable sensors placed for monitoring during the exercise session of their prehabilitation. The sensors will capture data during the single exercise session and transfer the data to a mobile health (mHealth) platform. The study aims to use the information from the sensors to develop future studies where the exercise is adjusted based on the sensor reports.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wearable sensors to capture movement-based data during physical therapy session. The Polar H10 Heart Rate Monitor measures heart rate and will transfer the data to the mHealth app.
Wearable sensors to capture movement-based data during physical therapy session. The Empatica EmbracePlus measures physiological parameters and will transfer the data to the mHealth app.
Wearable sensors to capture movement-based data during physical therapy session. The Apple Watch Ultra 2 measures heart rate, will transfer the data to the mHealth app, and will provide an alert when the heart rate is too high or too low.
Time frame: Day 1
Moderate intensity exercise is defined as a score of 3-5 on the Modified BORG CR10 Rating Perceived Exertion (RPE)
Time frame: Baseline
hand-held dynamometer, Newtons; Measures upper body strength
Time frame: Baseline
Number of times from chair sitting to standing in 30 seconds; Measures lower body strength and balance
Time frame: Baseline
meters per second; Measures walking speed over a short distance
Time frame: Baseline
seconds; time to stand up from a chair, walk a short distance, turn around, walk back to the chair, and sit down; Assess mobility and balance
Time frame: Baseline
6-minute walk distance, meters; If the test is not available a 5-meter test can be used
Time frame: Baseline
5-meter test, seconds; If the 6-minute walk test is not available a 5-meter test can be used
Time frame: Baseline
Record in units of cmH20; Measure of strength of inspiratory muscles
Time frame: Baseline
A binary assessment of whether the inspiratory muscle trainer required adjustment
Time frame: Day 1
Rate of perceived exertion as measured by Modified BORG CR10 Rating Perceived Exertion (RPE) scale of 0 (no exertion or resting) to 10 (pushing yourself to the max).
Time frame: Day 1
Rate of perceived exertion as measured by Modified BORG CR10 Rating Perceived Exertion (RPE) scale of 0 (no exertion or resting) to 10 (pushing yourself to the max).
Contact information is provided by the study sponsor or research team.
Darrel Cleere, BSN CCRP
CONTACT
Linda W Moore, PhD CCRP
CONTACT
The Methodist Hospital Research Institute
Other
Enabling Access to Prehabilitation for Kidney Transplant Candidates Who Are Frail
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07607041
Chronic Disease, Disease Attributes
View Trial DetailsNCT07224763
Chronic Disease, Disease Attributes
New York, United States
View Trial DetailsNCT07446296
Chronic Disease, Chronic Kidney Disease 5D
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04128189
Chronic Disease, DNA Virus Infections
Aurora, Colorado, United States
View Trial Details